BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5464330)

  • 1. Assay of serum fibrin degradation products by agglutination-inhibition of coated erythrocytes.
    Das PC
    J Clin Pathol; 1970 May; 23(4):299-303. PubMed ID: 5464330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tanned red cell hemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products. Methodological and statistical aspects.
    Hahn L
    Thromb Res; 1974 Mar; 4(3):417-36. PubMed ID: 4857332
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
    Wilson JE; Thornton RD
    Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-negative test for fibrinogen--fibrin degradation products.
    Kickler T; Bell WR
    Am J Clin Pathol; 1977 Jul; 68(1):78-80. PubMed ID: 868807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers.
    Largo R; Heller V; Straub PW
    Blood; 1976 Jun; 47(6):991-1002. PubMed ID: 132210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Agglutination of tanned rabbit erythrocytes sensitized by immunoglobulin G].
    Lecocq E; Linz R
    C R Seances Soc Biol Fil; 1971; 165(9):2032-4. PubMed ID: 4263150
    [No Abstract]   [Full Text] [Related]  

  • 7. The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.
    Garvey MB; Black JM
    J Clin Pathol; 1972 Aug; 25(8):680-2. PubMed ID: 5076802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of methods for the detection and quantitation of serum fibrin-fibrinogen degradation products.
    Erickson C; String T; Stewart D; Cohen RJ
    Am J Clin Pathol; 1972 Oct; 58(4):394-9. PubMed ID: 4674336
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemagglutination-inhibition technique with tanned erythrocytes coated with specific antibody (thyroglobulin antibody). A method for the study of the avidity of antisera.
    Hjort T
    Int Arch Allergy Appl Immunol; 1968; 34(5):437-54. PubMed ID: 4880137
    [No Abstract]   [Full Text] [Related]  

  • 10. Laser nephelometry quantitation of fibrinogen-related antigens.
    Ruiz-Arenas R; Lepe-Zuniga JL; Ruiz-Arguelles A; de Ruiz NL; Marin-Lopez A; Ruiz-Reyes G
    Am J Clin Pathol; 1981 Sep; 76(3):284-8. PubMed ID: 7282628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of fibrinogen-fibrin related antigen by continuous flow analysis.
    Nam D
    J Immunol Methods; 1975 Feb; 6(4):309-16. PubMed ID: 1168222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect hemagglutination with Mycoplasma antigens: effects of pH on antigen sensitization of tanned fresh and formalinized sheep erythrocytes.
    Krogsgaard-Jensen A
    Appl Microbiol; 1971 Nov; 22(5):756-9. PubMed ID: 5167212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fibrin-fibrinogen degradation products after experimental pulmonary embolism.
    Jones DR; Ruckley CV; Owens R; Cash JD
    Br J Surg; 1974 Oct; 61(10):811-3. PubMed ID: 4415741
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
    Shinada S
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
    Chi DS; Chen JP
    Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The measurement of fibrin-fibrinogen degradation products in dog urine.
    Wood RF; Gray AC; Pitcher PM
    Transplantation; 1974 Jul; 18(1):87-9. PubMed ID: 4837430
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J; Boneu B; Mignon-Conte ; Suc JM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
    Chi DS; Chen JP
    Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanned Red Cell Hemagglutination Inhibition Immunoassay for fibrinogen-fibrin-related antigen ("fibrinolytic degradation products") in human serum.
    Merskey C; Lalezari P; Johnson AJ
    Scand J Haematol Suppl; 1971; 13():83-5. PubMed ID: 5290706
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ; Cruz GO; Schumer BR
    Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.